Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Takeda launches Sunrise Patient Support Program for HAE patients
Sunrise is built on four elements i.e., awareness, screening & diagnosis, treatment, and maintenance support
Alembic Pharma gets EIR from USFDA for its solid oral formulation facility at Jarod
This was pre-approval inspection to cover Alembic’s solid oral drug products for which ANDAs were filed with USFDA
At Agilent, we believe that sustainability, productivity and efficiency can co-exist in a lab…
Dr Samir Vyas, Country General Manager, India, Agilent shares insights about the importance of sustainability, challenges…
Venus Remedies gets marketing approval for oncology medicines from Philippines, Iraq
Venus Remedies also expects marketing authorisation from Iraq for another commonly prescribed cancer drug, gemcitabine, to enhance…
Baxter to divest biopharma solutions business to Advent International and Warburg Pincus for $4.25…
Net proceeds planned to be redeployed for debt repayment in accordance with Baxter’s stated capital allocation priorities
Eisai enters into agreement with Blissbio for antibody-drug conjugate BB-1701
Based on the status of Phase I/II clinical trials of BB-1701 currently being conducted by BlissBio, both companies have decided to…
IOL gets CEP to export paracetamol to European market
At present, IOL has a total capacity of 3,600 tonnes to produce paracetamol
Cloud enhancing data sets for real-world clinical trials
Shivajyoti Bhattacharjee, VP – Healthcare & Life Sciences, Cybage Software highlights how RWD and RWE are pivotal to clinical…
CSIR-IICT signs MoU with 101 Therapeutics, Israel for COVID-19 drug
CSIR-IICT will be the knowledge partner for the clinical trial study and 101 Therapeutics, a CRO will manufacture the drug